WO2012019204A3 - Therapeutic agent for intranasal administration and method of making and using same - Google Patents

Therapeutic agent for intranasal administration and method of making and using same Download PDF

Info

Publication number
WO2012019204A3
WO2012019204A3 PCT/US2011/051981 US2011051981W WO2012019204A3 WO 2012019204 A3 WO2012019204 A3 WO 2012019204A3 US 2011051981 W US2011051981 W US 2011051981W WO 2012019204 A3 WO2012019204 A3 WO 2012019204A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutic agent
intranasal administration
making
same
nordihydrocapsaicin
Prior art date
Application number
PCT/US2011/051981
Other languages
French (fr)
Other versions
WO2012019204A2 (en
Inventor
Wayne Jeffrey Perry
Lynne M. Millheiser
Original Assignee
Dynova Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/849,088 external-priority patent/US20100322961A1/en
Application filed by Dynova Laboratories, Inc. filed Critical Dynova Laboratories, Inc.
Publication of WO2012019204A2 publication Critical patent/WO2012019204A2/en
Publication of WO2012019204A3 publication Critical patent/WO2012019204A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Abstract

The present invention provides a composition suitable for intranasal administration comprising capsaicin, dihydrocapsaicin, and nordihydrocapsaicin in the form of capsicum used as a therapeutic agent.
PCT/US2011/051981 2010-08-03 2011-09-16 Therapeutic agent for intranasal administration and method of making and using same WO2012019204A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12/849,088 US20100322961A1 (en) 2007-03-30 2010-08-03 Intranasal Drug Delivery System
US12/849,088 2010-08-03
US40539010P 2010-10-21 2010-10-21
US61/405,390 2010-10-21

Publications (2)

Publication Number Publication Date
WO2012019204A2 WO2012019204A2 (en) 2012-02-09
WO2012019204A3 true WO2012019204A3 (en) 2012-03-22

Family

ID=45560117

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2011/051976 WO2012019203A2 (en) 2010-08-03 2011-09-16 Therapeutic agent for intranasal administration and method of making and using same
PCT/US2011/051981 WO2012019204A2 (en) 2010-08-03 2011-09-16 Therapeutic agent for intranasal administration and method of making and using same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2011/051976 WO2012019203A2 (en) 2010-08-03 2011-09-16 Therapeutic agent for intranasal administration and method of making and using same

Country Status (1)

Country Link
WO (2) WO2012019203A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120171316A1 (en) * 2012-03-14 2012-07-05 Forces Of Nature, Inc. Method for manufacturing homeopathic mixtures
US20120183624A1 (en) * 2012-03-23 2012-07-19 Forces Of Nature, Inc. Method for manufacturing homeopathic personal care products
WO2014031964A1 (en) * 2012-08-24 2014-02-27 Vr1, Inc. Composition for the treatment of migraine headaches
MX370929B (en) 2012-10-28 2020-01-08 Revance Therapeutics Inc Compositions and methods for safe treatment of rhinitis.
US11484580B2 (en) 2014-07-18 2022-11-01 Revance Therapeutics, Inc. Topical ocular preparation of botulinum toxin for use in ocular surface disease

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151792A1 (en) * 2001-06-20 2004-08-05 Tripp Matthew L. Compositions that treat or inhibit pathological conditions associated with inflammatory response
US20090069433A1 (en) * 2007-09-10 2009-03-12 Wayne Jeffrey Perry Nasal rinse additive
US20090093446A1 (en) * 2007-10-05 2009-04-09 Winston Laboratories, Inc. Method for alleviating keratoconjunctivitis sicca
US20090312724A1 (en) * 2007-06-28 2009-12-17 Cydex Pharmaceuticals, Inc. Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151792A1 (en) * 2001-06-20 2004-08-05 Tripp Matthew L. Compositions that treat or inhibit pathological conditions associated with inflammatory response
US20090312724A1 (en) * 2007-06-28 2009-12-17 Cydex Pharmaceuticals, Inc. Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions
US20090069433A1 (en) * 2007-09-10 2009-03-12 Wayne Jeffrey Perry Nasal rinse additive
US20090093446A1 (en) * 2007-10-05 2009-04-09 Winston Laboratories, Inc. Method for alleviating keratoconjunctivitis sicca

Also Published As

Publication number Publication date
WO2012019203A2 (en) 2012-02-09
WO2012019203A3 (en) 2012-03-29
WO2012019204A2 (en) 2012-02-09

Similar Documents

Publication Publication Date Title
IL269858A (en) Pyridone and aza-pyridone compounds, pharmaceutical composition and kits comprising the same and uses thereof
IL269322B (en) Methylphenidate-prodrugs, processes of making and using the same
IL252154A0 (en) Anti-dr5 antibodies, compositions comprising the same and uses thereof
IL227963A0 (en) Cytotxic benzodiazepine derivatives, compositions comprising the same and uses thereof
HK1220631A1 (en) Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
WO2011130615A3 (en) Preparation of lacosamide
EP2670733A4 (en) Hdac inhibitors and therapeutic methods using the same
ZA201305571B (en) Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
WO2011002808A8 (en) Hcv protease inhibitors and uses thereof
PL2554050T3 (en) Combined chlorine agent, and manufacturing method and method of use for same
WO2011086584A3 (en) Improved process for the preparation of amide intermediates and their use thereof
WO2011150201A3 (en) Azolyl amide compounds and methods of use thereof
WO2012051117A3 (en) Substituted benzamides and their uses
WO2012019203A3 (en) Therapeutic agent for intranasal administration and method of making and using same
EP2361907A4 (en) The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof
WO2013155338A8 (en) Substituted benzamides and their uses
SG10201604468QA (en) Shk-based pharmaceutical compositions and methods of manufacturing and using the same
HK1200392A1 (en) Acetaminophen conjugates, compositions and methods of use thereof
IL227816A0 (en) Peptide library, constructs comprising the same and methods of use of the same
IL222780A0 (en) Pharmaceutical compositions comprising paracetamol and process for preparing the same
SG11201403785UA (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2011088272A9 (en) Selective ampd2 inhibitors and methods for using the same
IL230655A0 (en) N-hetero-ring-substituted amide derivatives, compositions comprising the same and uses thereof
WO2014159501A3 (en) Processes for preparing tetrahydroisoquinolines
WO2012139074A3 (en) Migrastatins and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11815428

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM XXXX DATED 09/04/2013)

122 Ep: pct application non-entry in european phase

Ref document number: 11815428

Country of ref document: EP

Kind code of ref document: A2